Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 11Breast 11Other hematologic neoplasm 5Thoracic 4Plasma cell 2Other solid neoplasm 2Other 2Myeloid 2Gynecologic 2Genitourinary 2Dermatologic 2Sarcoma 1CNS 1

Conditions

Peritoneal Neoplasms 1Hereditary Breast and Ovarian Cancer Syndrome 1Heart Diseases 1Breast Neoplasms 1

Interventions

Paclitaxel 581Carboplatin 528Cisplatin 359Bevacizumab 256pembrolizumab 228Gemcitabine 157liposomal doxorubicin 132Topotecan 131olaparib 129Cyclophosphamide 128Radiotherapy 118Taxes 114Docetaxel 95Brachytherapy 94Drug Therapy 91niraparib 88Doxorubicin 86Surveys and Questionnaires 85Magnetic Resonance Spectroscopy 80Blood Specimen Collection 74Nivolumab 71Specimen Handling 70Hyperthermic Intraperitoneal Chemotherapy 64Biopsy 63fludarabine 57Filgrastim 53Letrozole 50Oxaliplatin 49durvalumab 47Immunoglobulin G 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Echocardiography × Gynecologic × Clear all
NCT03510689 2024-10-16

Gene-HEART

Abramson Cancer Center at Penn Medicine

Completed
79 enrolled
BreastGynecologic

Breast Neoplasms, Heart Diseases, Hereditary Breast and Ovarian Cancer Syndrome

NCT01225757 2023-08-14

Comparison of Traditional and Echocardiography Guided Fluid Management During Cytoreductive Surgery With HIPEC

University of Nebraska

Phase NA Withdrawn
Gynecologic

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡